Namodenoson Shows Protective Effects Beyond Liver Cancer in Can-Fite’s Pivotal Study
Can-Fite BioPharma (NYSE: CANF) announced the publication of an innovative study in the European Society of Medicine...
Liver Cancer Healthcare
Namodenoson in Liver Cancer Treatment Alongside with Cardiac, Liver, and Neurological Benefits
Can-Fite BioPharma Ltd. Unlike chemotherapy with its known toxicity towards normal body systems, Namodenoson provides protective effects Ramat Gan, Israel,...
Projected epidemiological trends and burden of liver cancer by 2040 based on GBD, CI5plus, and WHO data
Liver cancer incidence and mortality rates estimates in 2020 and comparison by HDIAccording to the GLOBOCAN estimates, there were 905,000...
Liver Cancer Therapeutics Market to Hit USD 15.69 Billion
Pune, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Liver Cancer Therapeutics Market Size & Growth Analysis: “According to SNS Insider, The global...
New Liver Cancer Models Could Enable Precision Medicine
Credit: Rasi Bhadramani/Getty Images A team from Europe has created mouse models of liver cancer that could help overcome one...
Liver Cancer Therapeutics Market to Hit USD 15.69 Billion
Pune, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Liver Cancer Therapeutics Market Size & Growth Analysis: “According to SNS Insider, The global...
